There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434957 | PMC |
| http://dx.doi.org/10.1097/01.NPR.0000512253.40369.ab | DOI Listing |
Publication Analysis
Top Keywords
dipeptidyl peptidase-4
8
peptidase-4 inhibitors
8
patients type
8
type diabetes
8
kidney disease
8
options patients
8
inhibitors patients
4
diabetes chronic
4
chronic kidney
4
disease treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!